288 related articles for article (PubMed ID: 30340515)
1. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.
Jester R; Znoyko I; Garnovskaya M; Rozier JN; Kegl R; Patel S; Tran T; Abedalthagafi M; Horbinski CM; Richardson M; Wolff DJ; Lapadat R; Moore W; Rodriguez FJ; Mull J; Olar A
Acta Neuropathol Commun; 2018 Oct; 6(1):107. PubMed ID: 30340515
[TBL] [Abstract][Full Text] [Related]
2. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
3. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease.
Manski TJ; Heffner DK; Glenn GM; Patronas NJ; Pikus AT; Katz D; Lebovics R; Sledjeski K; Choyke PL; Zbar B; Linehan WM; Oldfield EH
JAMA; 1997 May; 277(18):1461-6. PubMed ID: 9145719
[TBL] [Abstract][Full Text] [Related]
4. Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry.
Bausch B; Wellner U; Peyre M; Boedeker CC; Hes FJ; Anglani M; de Campos JM; Kanno H; Maher ER; Krauss T; Sansó G; Barontini M; Letizia C; Hader C; Schiavi F; Zanoletti E; Suárez C; Offergeld C; Malinoc A; Zschiedrich S; Glasker S; Bobin S; Sterkers O; Ba Huy PT; Giraud S; Links T; Eng C; Opocher G; Richard S; Neumann HP;
Head Neck; 2016 Apr; 38 Suppl 1():E673-9. PubMed ID: 25867206
[TBL] [Abstract][Full Text] [Related]
5. Endolymphatic sac tumor with von Hippel-Lindau disease: report of a case with atypical pathology of endolymphatic sac tumor.
Yang X; Liu XS; Fang Y; Zhang XH; Zhang YK
Int J Clin Exp Pathol; 2014; 7(5):2609-14. PubMed ID: 24966975
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features of low-grade malignant endolymphatic sac tumors.
Wang HQ; Jie L; Shi HY
Pathol Res Pract; 2018 Mar; 214(3):431-435. PubMed ID: 29482989
[TBL] [Abstract][Full Text] [Related]
7. Endolymphatic sac tumor misdiagnosed as metastatic renal cell carcinoma: Pitfalls in morphology and immunohistochemistry.
Sun W; Wang M; Yue J
Clin Neuropathol; 2024; 43(2):43-47. PubMed ID: 38495013
[TBL] [Abstract][Full Text] [Related]
8. The vestibular aqueduct: site of origin of endolymphatic sac tumors.
Lonser RR; Baggenstos M; Kim HJ; Butman JA; Vortmeyer AO
J Neurosurg; 2008 Apr; 108(4):751-6. PubMed ID: 18377255
[TBL] [Abstract][Full Text] [Related]
9. [Tumour staged surgery of endolymphatic sac tumors (ELST)].
Schipper J; Maier W; Rosahl S; Berlis A; Laszig R
Laryngorhinootologie; 2004 Aug; 83(8):493-500. PubMed ID: 15316888
[TBL] [Abstract][Full Text] [Related]
10. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): report of two cases with analysis of the VHL gene.
Skalova A; Síma R; Bohus P; Curík R; Lukás J; Michal M
Pathol Res Pract; 2008; 204(8):599-606. PubMed ID: 18423895
[TBL] [Abstract][Full Text] [Related]
11. Endolymphatic sac tumors: experience of three cases.
Bastier PL; de Mones E; Marro M; Elkhatib W; Franco-Vidal V; Liguoro D; Darrouzet V
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1551-7. PubMed ID: 23212692
[TBL] [Abstract][Full Text] [Related]
12. Effects of VHL deficiency on endolymphatic duct and sac.
Gläsker S; Lonser RR; Tran MG; Ikejiri B; Butman JA; Zeng W; Maxwell PH; Zhuang Z; Oldfield EH; Vortmeyer AO
Cancer Res; 2005 Dec; 65(23):10847-53. PubMed ID: 16322231
[TBL] [Abstract][Full Text] [Related]
13. Endolymphatic sac tumor (aggressive papillary tumor of middle ear and temporal bone): sine qua non radiology-pathology and the University of Texas MD Anderson Cancer Center experience.
Bell D; Gidley P; Levine N; Fuller GN
Ann Diagn Pathol; 2011 Apr; 15(2):117-23. PubMed ID: 21167761
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features of endolymphatic sac tumor at cerebellopontine angle].
Du J; Wang JM; Cui Y; Li GL
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):590-4. PubMed ID: 22177241
[TBL] [Abstract][Full Text] [Related]
15. Endolymphatic sac tumors: clinical outcome and management in a series of 9 cases.
Timmer FC; Neeskens LJ; van den Hoogen FJ; Slootweg PJ; Dunnebier EA; Pauw BK; Mulder JJ; Cremers CW; Kunst HP
Otol Neurotol; 2011 Jun; 32(4):680-5. PubMed ID: 21451430
[TBL] [Abstract][Full Text] [Related]
16. Endolymphatic sac tumors in von Hippel-Lindau disease: report of three cases.
Codreanu CM; Duet M; Hautefort C; Wassef M; Guichard JP; Giraud S; Richard S; Roqueplo AP; Tran Ba Huy P
Otol Neurotol; 2010 Jun; 31(4):660-4. PubMed ID: 20351605
[TBL] [Abstract][Full Text] [Related]
17. Endolymphatic sac tumor associated with a von Hippel-Lindau disease patient: an immunohistochemical study.
Horiguchi H; Sano T; Toi H; Kageji T; Hirokawa M; Nagahiro S
Mod Pathol; 2001 Jul; 14(7):727-32. PubMed ID: 11455007
[TBL] [Abstract][Full Text] [Related]
18. Endolymphatic sac tumor: single-institution series of seven cases with updated review of literature.
Talukdar R; Epari S; Sahay A; Choudhari A; Dasgupta A; Chatterjee A; Gupta T
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2591-2598. PubMed ID: 34410472
[TBL] [Abstract][Full Text] [Related]
19. Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status.
Bambakidis NC; Megerian CA; Ratcheson RA
Otol Neurotol; 2004 Sep; 25(5):773-81. PubMed ID: 15354010
[TBL] [Abstract][Full Text] [Related]
20. Endolymphatic sac tumour - a rare complication associated with von Hippel-Lindau disease.
Wozniaková M; Židlík V; Škarda J
Cesk Patol; 2023; 59(1):32-35. PubMed ID: 37072278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
